← FDA Drug Approvals (Drugs@FDA)

RITUXAN HYCELA

BLA · Biologics License Application · Sponsor: GENENTECH INC · Approved 2017-06-22

Drug application

FDA Application #

BLA761064

Application type

Biologics License Application

Brand name

RITUXAN HYCELA

Generic name

RITUXIMAB AND HYALURONIDASE

Active ingredients

RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

GENENTECH INC

Manufacturer

Genentech, Inc.

First approval

2017-06-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown